Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glioma
|
353 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Breast Carcinoma
|
2793 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Cancer of Digestive System
|
15 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Diffuse Large B-Cell Lymphoma
|
127 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
endocrine system cancer
|
1 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Hematopoietic Neoplasms
|
2 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Malignant neoplasm of breast
|
3417 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Malignant neoplasm of prostate
|
1082 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Neoplasms
|
1644 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Prostate carcinoma
|
1168 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Small cell carcinoma of lung
|
125 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Small cell lung cancer limited stage
|
2 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Rhegmatogenous retinal detachment
|
8 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||||
Non-Small Cell Lung Carcinoma
|
712 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Proliferative vitreoretinopathy
|
14 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Squamous cell carcinoma of esophagus
|
329 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Malignant Neoplasms
|
1641 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.060 | 1.000 | 6 | 2014 | 2017 | ||||||
Primary malignant neoplasm
|
1374 | 0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv | 0.050 | 1.000 | 5 | 2014 | 2017 |